Note: You clicked on an external link, which has been disabled in order to keep your shopping session open.
|Tested species reactivity||Human|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Synthetic peptide derived from N-terminus of human BIM.|
|Purification||Antigen affinity chromatography|
|Storage buffer||PBS, pH 7.6, with 1% BSA|
|Contains||<0.1% sodium azide|
|Storage Conditions||4° C, do not freeze|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||1:25|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
Heat-mediated antigen retrieval is recommended prior to staining, using a 10mM citrate buffer, pH 6.0, for 10 minutes followed by cooling at room temperature for 20 min. Following antigen retrieval, incubate samples with primary antibody for 30 min at room temperature. A suggested positive control is placenta tissue.
BIM/BOD (BCL-2-related Ovarian Death Gene). It belongs to BCL-2 family of proteins containing BCL-2 homology domain3 (BH3). It is proapoptotic and exerts its effects by interacting with prosurvival members of the BCL-2 family like BCL-2, BCL-XL and BCL-W. It exhibits three splice variants; BimL, BimS and BimEL. They all share homology in their C-terminal BH3 domain and are ubiquitously expressed. BimS is the strongest of them with respect to the proapoptotic capacity.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
BAM; bcl-2 interacting mediator of cell death; bcl-2 interacting protein Bim; bcl-2-like protein 11; bcl-2-related ovarian death agonist; bcl2-L-11; BCL2-like 11 (apoptosis facilitator); BIM; BIM-alpha6; BIM-beta6; BIM-beta7; BimEL; BimL; BOD
BAM; BCL2L11; BIM; BOD